MATTHIAS
DROSTEN
Investigador
University of California, San Francisco
San Francisco, Estados UnidosPublicacions en col·laboració amb investigadors/es de University of California, San Francisco (3)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2018
-
Allele-specific mechanisms of activation of mek1 mutants determine their properties
Cancer Discovery, Vol. 8, Núm. 5, pp. 648-661
2017
-
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Nature, Vol. 548, Núm. 7666, pp. 234-238